In line with our finding, SMARCA4 has also been found to be highly upregulated and promote cancer development in other organ systems, such as prostate cancer [24], breast cancer [25], liver cancer [12], gastric cancer [41] and melanoma [29]. This evidence concerns the gene SMARCA4 and prostate cancer.